Entactbio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$10M
- Investors
-
14
Entactbio General Information
Description
Developer of a biotechnology research company designed to enhance the function of beneficial proteins. The company engages in natural cellular mechanisms by offering small-molecule drugs to create enhancement-targeting chimeric medicines, enabling patients to harness the ability of enzymes to regulate proteins.
Contact Information
Website
www.entactbio.comCorporate Office
- 65 Grove Street
- Suite 303
- Watertown, MA 02472
- United States
Corporate Office
- 65 Grove Street
- Suite 303
- Watertown, MA 02472
- United States
Entactbio Timeline
Entactbio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A2) | 03-Jun-2026 | $10M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A2) | 15-May-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 06-Dec-2022 | $81M | $86.4M | Completed | Generating Revenue | |
| 1. Seed Round | 25-Oct-2019 | $5.4M | $5.4M | Completed | Startup |
Entactbio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 | ||||||||
| Series A | 10,664,312 | $0.000010 | 8% | $2.49 | $2.49 | 1x | $2.49 | 13.28% |
| Seed | 4,000,000 | $0.000010 | 8% | $1.35 | $1.35 | 1x | $1.35 | 4.98% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Entactbio Comparisons
Industry
Financing
Details
Entactbio Competitors (3)
One of Entactbio’s 3 competitors is Arzeda, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arzeda | Venture Capital-Backed | Seattle, WA | ||||
| Spark Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Codexis | Formerly VC-backed | Redwood City, CA |
Entactbio Patents
Entactbio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022148822-A1 | Usp5 binding survival-targeting chimeric (surtac) molecules & uses thereof | Inactive | 07-Jan-2021 | ||
| WO-2022148821-A1 | Usp7 binding survival-targeting chimeric (surtac) molecules & uses thereof | Inactive | 07-Jan-2021 | ||
| WO-2020169650-A1 | Survival-targeting chimeric (surtac) molecules | Inactive | 21-Feb-2019 | A61K47/6811 |
Entactbio Signals
Entactbio Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| WEHI Ventures | Corporate Venture Capital | Minority | ||
| Revelation Partners | Venture Capital | Minority | ||
| Abingworth | Venture Capital | Minority | ||
| Brandon Biocatalyst | Venture Capital | Minority | ||
| Brandon Capital | Venture Capital | Minority |
Entactbio FAQs
-
When was Entactbio founded?
Entactbio was founded in 2019.
-
Where is Entactbio headquartered?
Entactbio is headquartered in Watertown, MA.
-
What is the size of Entactbio?
Entactbio has 23 total employees.
-
What industry is Entactbio in?
Entactbio’s primary industry is Drug Discovery.
-
Is Entactbio a private or public company?
Entactbio is a Private company.
-
What is the current valuation of Entactbio?
The current valuation of Entactbio is .
-
What is Entactbio’s current revenue?
The current revenue for Entactbio is .
-
How much funding has Entactbio raised over time?
Entactbio has raised $137M.
-
Who are Entactbio’s investors?
WEHI Ventures, Revelation Partners, Abingworth, Brandon Biocatalyst, and Brandon Capital are 5 of 14 investors who have invested in Entactbio.
-
Who are Entactbio’s competitors?
Arzeda, Spark Therapeutics, and Codexis are competitors of Entactbio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process